NYSE - Nasdaq Real Time Price USD

Klaviyo, Inc. (KVYO)

Compare
39.06 -0.18 (-0.46%)
At close: December 13 at 4:00:02 PM EST
38.51 -0.55 (-1.41%)
Pre-Market: 5:31:53 AM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 235.09M
Earnings -1.34M
Q4'23
Q1'24
Q2'24
Q3'24
0
50M
100M
150M
200M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

35.00 Low
42.20 Average
39.06 Current
47.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 18181818
Avg. Estimate 0.060.140.490.57
Low Estimate 0.040.110.470.54
High Estimate 0.070.170.50.65
Year Ago EPS 0.090.130.360.49

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 19192020
Avg. Estimate 257.24M264.71M924.49M1.15B
Low Estimate 256.1M260M923.4M1.14B
High Estimate 258.17M268.1M925.37M1.16B
Year Ago Sales 201.62M209.99M698.1M924.49M
Sales Growth (year/est) 27.59%26.05%32.43%24.90%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.080.110.10.11
EPS Actual 0.090.130.150.15
Difference 0.010.020.050.04
Surprise % 15.07%19.36%53.01%39.87%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.060.140.490.57
7 Days Ago 0.060.140.490.57
30 Days Ago 0.060.140.490.57
60 Days Ago 0.10.140.480.58
90 Days Ago 0.10.140.480.58

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --314
Up Last 30 Days --314
Down Last 7 Days 176--13
Down Last 30 Days 155--12

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
KVYO -34.36%6.64%35.57%17.16%
S&P 500 5.00%12.00%2.10%12.20%

Upgrades & Downgrades

Maintains Keybanc: Overweight to Overweight 12/13/2024
Maintains Macquarie: Neutral to Neutral 11/8/2024
Maintains Needham: Buy to Buy 11/7/2024
Maintains Canaccord Genuity: Buy to Buy 11/7/2024
Maintains Baird: Outperform to Outperform 11/7/2024
Maintains Cantor Fitzgerald: Overweight to Overweight 11/7/2024

Related Tickers